Global Advanced Parenteral drug delivery Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 100

Report ID: 6380

Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.

The global Advanced Parenteral drug delivery market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Advanced Parenteral drug delivery volume and value at global level, regional level and company level. From a global perspective, this report represents overall Advanced Parenteral drug delivery market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices

Segment by Application
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others

Table of Contents

Executive Summary
1 Advanced Parenteral drug delivery Market Overview
1.1 Product Overview and Scope of Advanced Parenteral drug delivery
1.2 Advanced Parenteral drug delivery Segment by Type
1.2.1 Global Advanced Parenteral drug delivery Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Prefillable Syringes
1.2.3 Injectors Cartridges
1.2.4 Hypodermic Syringes
1.2.5 IV Catheters
1.2.6 Other Parenteral Delivery Devices
1.3 Advanced Parenteral drug delivery Segment by Application
1.3.1 Advanced Parenteral drug delivery Consumption Comparison by Application (2014-2025)
1.3.2 Government Hospitals
1.3.3 Private Hospitals and Clinics
1.3.4 Healthcare Organizations
1.3.5 Others
1.4 Global Advanced Parenteral drug delivery Market by Region
1.4.1 Global Advanced Parenteral drug delivery Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Advanced Parenteral drug delivery Market Size
1.5.1 Global Advanced Parenteral drug delivery Revenue (2014-2025)
1.5.2 Global Advanced Parenteral drug delivery Production (2014-2025)

2 Global Advanced Parenteral drug delivery Market Competition by Manufacturers
2.1 Global Advanced Parenteral drug delivery Production Market Share by Manufacturers (2014-2019)
2.2 Global Advanced Parenteral drug delivery Revenue Share by Manufacturers (2014-2019)
2.3 Global Advanced Parenteral drug delivery Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Advanced Parenteral drug delivery Production Sites, Area Served, Product Types
2.5 Advanced Parenteral drug delivery Market Competitive Situation and Trends
2.5.1 Advanced Parenteral drug delivery Market Concentration Rate
2.5.2 Advanced Parenteral drug delivery Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Advanced Parenteral drug delivery Production Market Share by Regions
3.1 Global Advanced Parenteral drug delivery Production Market Share by Regions
3.2 Global Advanced Parenteral drug delivery Revenue Market Share by Regions (2014-2019)
3.3 Global Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Advanced Parenteral drug delivery Production
3.4.1 North America Advanced Parenteral drug delivery Production Growth Rate (2014-2019)
3.4.2 North America Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Advanced Parenteral drug delivery Production
3.5.1 Europe Advanced Parenteral drug delivery Production Growth Rate (2014-2019)
3.5.2 Europe Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Advanced Parenteral drug delivery Production (2014-2019)
3.6.1 China Advanced Parenteral drug delivery Production Growth Rate (2014-2019)
3.6.2 China Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Advanced Parenteral drug delivery Production (2014-2019)
3.7.1 Japan Advanced Parenteral drug delivery Production Growth Rate (2014-2019)
3.7.2 Japan Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Advanced Parenteral drug delivery Consumption by Regions
4.1 Global Advanced Parenteral drug delivery Consumption by Regions
4.2 North America Advanced Parenteral drug delivery Consumption (2014-2019)
4.3 Europe Advanced Parenteral drug delivery Consumption (2014-2019)
4.4 China Advanced Parenteral drug delivery Consumption (2014-2019)
4.5 Japan Advanced Parenteral drug delivery Consumption (2014-2019)

5 Global Advanced Parenteral drug delivery Production, Revenue, Price Trend by Type
5.1 Global Advanced Parenteral drug delivery Production Market Share by Type (2014-2019)
5.2 Global Advanced Parenteral drug delivery Revenue Market Share by Type (2014-2019)
5.3 Global Advanced Parenteral drug delivery Price by Type (2014-2019)
5.4 Global Advanced Parenteral drug delivery Production Growth by Type (2014-2019)

6 Global Advanced Parenteral drug delivery Market Analysis by Applications
6.1 Global Advanced Parenteral drug delivery Consumption Market Share by Application (2014-2019)
6.2 Global Advanced Parenteral drug delivery Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Advanced Parenteral drug delivery Business
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Advanced Parenteral drug delivery Production Sites and Area Served
7.1.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.1.3 Abbott Laboratories Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Amgen
7.2.1 Amgen Advanced Parenteral drug delivery Production Sites and Area Served
7.2.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.2.3 Amgen Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Pfizer
7.3.1 Pfizer Advanced Parenteral drug delivery Production Sites and Area Served
7.3.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.3.3 Pfizer Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Hoffmann-La Roche
7.4.1 Hoffmann-La Roche Advanced Parenteral drug delivery Production Sites and Area Served
7.4.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.4.3 Hoffmann-La Roche Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 AstraZeneca
7.5.1 AstraZeneca Advanced Parenteral drug delivery Production Sites and Area Served
7.5.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.5.3 AstraZeneca Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Baxter
7.6.1 Baxter Advanced Parenteral drug delivery Production Sites and Area Served
7.6.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.6.3 Baxter Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Dickinson
7.7.1 Dickinson Advanced Parenteral drug delivery Production Sites and Area Served
7.7.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.7.3 Dickinson Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Boston Scientific
7.8.1 Boston Scientific Advanced Parenteral drug delivery Production Sites and Area Served
7.8.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.8.3 Boston Scientific Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Advanced Parenteral drug delivery Production Sites and Area Served
7.9.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.9.3 Bristol-Myers Squibb Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Advanced Parenteral drug delivery Production Sites and Area Served
7.10.2 Advanced Parenteral drug delivery Product Introduction, Application and Specification
7.10.3 GlaxoSmithKline Advanced Parenteral drug delivery Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Novartis
7.12 Becton
7.13 AptarGroup

8 Advanced Parenteral drug delivery Manufacturing Cost Analysis
8.1 Advanced Parenteral drug delivery Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Advanced Parenteral drug delivery
8.4 Advanced Parenteral drug delivery Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Advanced Parenteral drug delivery Distributors List
9.3 Advanced Parenteral drug delivery Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Advanced Parenteral drug delivery Market Forecast
11.1 Global Advanced Parenteral drug delivery Production, Revenue Forecast
11.1.1 Global Advanced Parenteral drug delivery Production Growth Rate Forecast (2019-2025)
11.1.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Advanced Parenteral drug delivery Price and Trend Forecast (2019-2025)
11.2 Global Advanced Parenteral drug delivery Production Forecast by Regions (2019-2025)
11.2.1 North America Advanced Parenteral drug delivery Production, Revenue Forecast (2019-2025)
11.2.2 Europe Advanced Parenteral drug delivery Production, Revenue Forecast (2019-2025)
11.2.3 China Advanced Parenteral drug delivery Production, Revenue Forecast (2019-2025)
11.2.4 Japan Advanced Parenteral drug delivery Production, Revenue Forecast (2019-2025)
11.3 Global Advanced Parenteral drug delivery Consumption Forecast by Regions (2019-2025)
11.3.1 North America Advanced Parenteral drug delivery Consumption Forecast (2019-2025)
11.3.2 Europe Advanced Parenteral drug delivery Consumption Forecast (2019-2025)
11.3.3 China Advanced Parenteral drug delivery Consumption Forecast (2019-2025)
11.3.4 Japan Advanced Parenteral drug delivery Consumption Forecast (2019-2025)
11.4 Global Advanced Parenteral drug delivery Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Advanced Parenteral drug delivery Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer